The COLchicine and Atrial FIBrillation Trial

PHASE3RecruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

June 14, 2026

Study Completion Date

November 1, 2028

Conditions

Atrial Fibrillation

Interventions

DRUG

Colchicine

Colchicine 0.5 mg once daily

DRUG

Placebo

Placebo once daily

Trial Locations (1)

RECRUITING

Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR), Hellerup

All Listed Sponsors

lead

Herlev and Gentofte Hospital

OTHER